{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:49:34Z","timestamp":1793047774304,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00702-014-1317-9","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T05:22:19Z","timestamp":1411622539000},"page":"721-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI"],"prefix":"10.1007","volume":"122","author":[{"given":"H. P.","family":"Sigurdsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ben-Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"K\u00f6stlbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wenzel-Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Haen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"1317_CR1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(05)66665-2","volume":"365","author":"GS Alexopoulos","year":"2005","unstructured":"Alexopoulos GS (2005) Depression in the elderly. Lancet 365:1961\u20131970","journal-title":"Lancet"},{"key":"1317_CR2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/gps.1190","volume":"19","author":"P Allard","year":"2004","unstructured":"Allard P, Gram L, Timdahl K, Behnke K, Hanson M, Sogaard J (2004) Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram. Int J Geriatr Psych 19:1123\u20131130","journal-title":"Int J Geriatr Psych"},{"key":"1317_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0165-0327(97)00153-5","volume":"46","author":"M Amore","year":"1997","unstructured":"Amore M, Ricci M, Zanardi R, Perez J, Ferrari G (1997) Long-term treatment of geropsychiatric depressed patients with venlafaxine. J Affect Disorders 46:293\u2013296","journal-title":"J Affect Disorders"},{"issue":"3","key":"1317_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/gerona\/58.3.M249","volume":"58A","author":"DG Blazer","year":"2003","unstructured":"Blazer DG (2003) Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 58A(3):249\u2013265","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1317_CR5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2012.05.010","volume":"142","author":"D B\u00fcchtemann","year":"2012","unstructured":"B\u00fcchtemann D, Luppa M, Bramesfeld A, Riedel-Heller S (2012) Incidence of late-life depression: a systematic review. J Affect Disorders 142:172\u2013179","journal-title":"J Affect Disorders"},{"key":"1317_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d4551","volume":"343","author":"C Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:1\u201315","journal-title":"BMJ"},{"issue":"3","key":"1317_CR7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10401239609147754","volume":"8","author":"M Dierick","year":"1996","unstructured":"Dierick M (1996) An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients. Ann Clin Psychiatry 8(3):169\u2013178","journal-title":"Ann Clin Psychiatry"},{"issue":"5","key":"1317_CR8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0893-133X(98)00113-4","volume":"20","author":"SM Fogelman","year":"1999","unstructured":"Fogelman SM, Schmider J, venkatakrishnan K, von Moltke LL, Harmatz JS, Shader RI, Greenblatt DJ (1999) O- and N-demethylation of venlafaxine in vitro by human liver mucrosomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants. Neuropsychopharmacol 20(5):480\u2013490","journal-title":"Neuropsychopharmacol"},{"key":"1317_CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pharmtox.44.101802.121453","volume":"44","author":"M Gandhi","year":"2004","unstructured":"Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF (2004) Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol 44:499\u2013523","journal-title":"Annu Rev Pharmacol"},{"issue":"1","key":"1317_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004714-200302000-00004","volume":"23","author":"C Gast\u00f3","year":"2003","unstructured":"Gast\u00f3 C, Navarro V, Marcos T, Portella MJ, Torra M, Rodamilans M (2003) Single-blind comparison of venlafaxine and nortriptyline in elderly major depression. J Clin Psychopharm 23(1):21\u201326","journal-title":"J Clin Psychopharm"},{"key":"1317_CR11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.57.5.503","volume":"57","author":"AT Harvey","year":"2000","unstructured":"Harvey AT, Rudolph RL, Preskorn SH (2000) Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiat 57:503\u2013509","journal-title":"Arch Gen Psychiat"},{"issue":"6","key":"1317_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Zernig G (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44(6):195\u2013235","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"1317_CR13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00003495-199549020-00010","volume":"49","author":"SM Holliday","year":"1995","unstructured":"Holliday SM, Benfield P (1995) Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs 49(2):280\u2013294","journal-title":"Drugs"},{"issue":"3","key":"1317_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-0447.2001.00299.x","volume":"104","author":"J Kirchheiner","year":"2001","unstructured":"Kirchheiner J, Brosen K, Dahl ML, Gram LF, Kasper S, Roots I, Brockm\u00f6ller J (2001) CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages. Acta Psychiat Scand 104(3):173\u2013192","journal-title":"Acta Psychiat Scand"},{"issue":"5","key":"1317_CR15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/j.1875-9114.1996.tb03009.x","volume":"16","author":"KJ Klamerus","year":"1996","unstructured":"Klamerus KJ, Parker VD, Rudolph RL, Derivan AT, Chiang ST (1996) Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokinetics. Pharmacotherapy 16(5):915\u2013923","journal-title":"Pharmacotherapy"},{"key":"1317_CR16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biopsych.2006.10.001","volume":"62","author":"S Kloiber","year":"2007","unstructured":"Kloiber S, Ising M, Reppermund S, Horstmann S, Dose T, Majer M, Lucae S (2007) Overweight and obesity affect treatment response in major depression. Biol psychiat 62:321\u2013326","journal-title":"Biol psychiat"},{"key":"1317_CR17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","volume":"370","author":"L Mallet","year":"2007","unstructured":"Mallet L, Spinewine A, Huang A (2007) The challenge of managing drug interactions in elderly people. Lancet 370:185\u2013191","journal-title":"Lancet"},{"key":"1317_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852913000746","volume":"18","author":"D Marazziti","year":"2013","unstructured":"Marazziti D, Baroni S, Picchetti M, Piccinni A, Carlini M, Vatteroni E, Dell\u00b4Osso L (2013) Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex. CNS Spectr 18:1\u201310","journal-title":"CNS Spectr"},{"issue":"1","key":"1317_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/FTD.0b013e3181fcf94d","volume":"33","author":"DE McAlpine","year":"2011","unstructured":"McAlpine DE, Biernacka JM, Mrazek DA, O\u00b4Kane DJ, Stevens SR, Langman LJ, Moyer TP (2011) Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine. Ther Drug Monit 33(1):14\u201320","journal-title":"Ther Drug Monit"},{"key":"1317_CR20","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1093\/ndt\/gfs295","volume":"27","author":"EV Nagler","year":"2012","unstructured":"Nagler EV, Webster AC, Vanholder R, Zoccali C (2012) Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transpl 27:3736\u20133745","journal-title":"Nephrol Dial Transpl"},{"key":"1317_CR21","unstructured":"Pfizer (2013) Retrieved 15 May 2013 from http:\/\/www.fachinfo.de\/data\/fi\/jsearch?wirkstoff"},{"issue":"6","key":"1317_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0165-6147(00)01717-X","volume":"22","author":"M Pirmohamed","year":"2001","unstructured":"Pirmohamed M, Park BK (2001) Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci 22(6):298\u2013305","journal-title":"Trends Pharmacol Sci"},{"key":"1317_CR23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00007691-200208000-00014","volume":"24","author":"M Reis","year":"2002","unstructured":"Reis M, Lundmark J, Bj\u00f6rk H, Bengtsson F (2002) Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting. Ther Drug Monit 24:533\u2013545","journal-title":"Ther Drug Monit"},{"issue":"1","key":"1317_CR24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","volume":"31","author":"M Reis","year":"2009","unstructured":"Reis M, Aamo T, Spigset O, Ahlner J (2009) Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther Drug Monit 31(1):42\u201356","journal-title":"Ther Drug Monit"},{"issue":"1","key":"1317_CR25","first-page":"70","volume":"24","author":"A Rostami-Hodjegan","year":"2004","unstructured":"Rostami-Hodjegan A, Amin AM, Spencer EP, Lennard MS, Tucker GT, Flanagan RJ (2004) Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients. J Clin Pharmacol 24(1):70\u201378","journal-title":"J Clin Pharmacol"},{"key":"1317_CR26","unstructured":"Schmitt G, Herbold M, Peters F (2003). Methodenvalidierung im forensisch-toxikologischen labor. In: Herbold M (ed) Arvecon, Germany"},{"key":"1317_CR27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2710.2006.00763.x","volume":"331","author":"MEE Shams","year":"2006","unstructured":"Shams MEE, Arneth B, Hiemke C, Dragicevic A, M\u00fcller MJ, Kaiser R, H\u00e4rtter S (2006) CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther 331:493\u2013502","journal-title":"J Clin Pharm Ther"},{"key":"1317_CR28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ACO.0b013e328339ef22","volume":"23","author":"A Singh","year":"2010","unstructured":"Singh A, Antognini JF (2010) Perioperative pharmacology in elderly patients. Curr Opin Anesthesio 23:449\u2013454","journal-title":"Curr Opin Anesthesio"},{"key":"1317_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","volume":"178","author":"ME Thase","year":"2001","unstructured":"Thase ME, Entsuah AR, Rudolph RL (2001) Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Brit J Psychiat 178:234\u2013241","journal-title":"Brit J Psychiat"},{"key":"1317_CR30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","volume":"38","author":"K Turnheim","year":"2003","unstructured":"Turnheim K (2003) When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38:843\u2013853","journal-title":"Exp Gerontol"},{"issue":"6","key":"1317_CR31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/FTD.0b013e318237b0fa","volume":"33","author":"S Unterecker","year":"2011","unstructured":"Unterecker S, Deckert J, Pfuhlmann B (2011) No influence of body weight on serum levels of antidepressants. Ther Drug Monit 33(6):730\u2013734","journal-title":"Ther Drug Monit"},{"issue":"6","key":"1317_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0032-1326769","volume":"45","author":"S Unterecker","year":"2012","unstructured":"Unterecker S, Hiemke C, Greiner C, Haen E, Jabs B, Deckert J, Pfuhlmann B (2012) The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions. Pharmacopsychiatry 45(6):229\u2013235","journal-title":"Pharmacopsychiatry"},{"issue":"8","key":"1317_CR33","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-012-0952-2","volume":"120","author":"S Unterecker","year":"2013","unstructured":"Unterecker S, Riederer P, Proft F, Maloney J, Deckert J, Pfuhlmann B (2013) Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions. J Neural Transm 120(8):1237\u20131246","journal-title":"J Neural Transm"},{"issue":"1","key":"1317_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FTD.0b013e318241dce0","volume":"34","author":"RB Waade","year":"2012","unstructured":"Waade RB, Molden E, Refsum H, Hermann M (2012) Serum concentrations of antidepressants in the elderly. Ther Drug Monit 34(1):25\u201329","journal-title":"Ther Drug Monit"},{"key":"1317_CR35","volume-title":"International statistical classification of diseases and health related problems","author":"WHO","year":"2004","unstructured":"WHO (2004) International statistical classification of diseases and health related problems. World Health Organization, Geneva"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-014-1317-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1317-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T22:54:04Z","timestamp":1717368844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-014-1317-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1317"],"URL":"https:\/\/doi.org\/10.1007\/s00702-014-1317-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}